
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Independently author, edit, and finalize complex regulatory documents supporting clinical development programs. • Lead FDA briefing documents for RMAT, Breakthrough Therapy Designation, and other Agency interactions. • Develop clinical protocol synopses and contribute to full clinical study protocols. • Collaborate with Clinical Development, Regulatory Affairs, Biostatistics, Clinical Operations, Translational Medicine, and other functional teams. • Manage document development timelines, reviews, cross-functional feedback, and delivery schedules. • Ensure documents align with FDA guidance, ICH guidelines, and company standards. • Participate in document planning meetings and provide strategic input on structure, messaging, and regulatory presentation. • Support additional regulatory and clinical documents as business needs evolve.
• Advanced degree (PhD, PharmD, MD, MS, or equivalent) in Life Sciences, Pharmacy, Medicine, or a related scientific discipline preferred. • 10+ years of medical writing experience within the biotechnology or pharmaceutical industry. • Extensive experience independently authoring FDA regulatory documents, including briefing packages, meeting requests, and clinical development documents. • Experience developing FDA briefing documents supporting RMAT, Breakthrough Therapy Designation, or similar regulatory interactions. • Strong experience writing clinical protocols and protocol synopses. • Thorough understanding of FDA regulations, ICH guidelines, and GCP requirements. • Ability to independently manage multiple projects with minimal supervision while meeting aggressive timelines. • Exceptional scientific writing, editing, communication, and project management skills. • Experience working in fast-paced, cross-functional clinical development environments. • West coast hours preferred.
• Bonus eligibility • Health and other benefits • Participation in the Company’s stock plan
Apply Now🔥 4 hours ago
Medical Writing FSP leader overseeing global clinical-trial writing operations for Thermo Fisher Scientific, the world leader in serving science. Managing teams, budgets, regulatory strategy, client relationships, and new business development.
🇺🇸 United States – Remote
💵 $245k - $260k / year
⏰ Full Time
🟠 Senior
✏️ Content Writer
🦅 H1B Visa Sponsor
🔥 14 hours ago
Medical writing manager leading regulatory documents and teams for pharmaceutical/CRO clients. Preparing clinical, safety, and submission documents across clinical development phases while managing quality, timelines, and budgets.
🔥 14 hours ago
Medical writing manager leading regulatory documents and a 4–10-person writing team. Supporting pharmaceutical and CRO client projects across clinical development and submissions.
🕒 Yesterday
B2B proposal writer translating complex connected-device services into persuasive RFP responses and sales materials for Assurant. Shaping differentiated narratives that help global brands win high-stakes client decisions.
🇺🇸 United States – Remote
💵 $64.9k - $108.2k / year
💰 Post-IPO Debt on 2023-02
⏰ Full Time
🟡 Mid-level
🟠 Senior
✏️ Content Writer
🦅 H1B Visa Sponsor
🕒 2 days ago
Global Financial Content Writer creating accessible personal finance education for LearnLux’s workplace financial wellbeing platform. Adapting lessons across countries while maintaining accuracy, editorial quality, and local financial context.